Arcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should Know

A director of Arcutis Biotherapeutics reported selling 10,000 shares for a total transaction value of $239,000 on April 1, 2026. This sale represented 20.10% of Howard G.